Inogen, Inc INGN
5.36
0.13
2.49%
as of 25 Sep
- Market cap
- $138.8M
- P/E
- 0.0×
Follow INGN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (13.14%) | (13.07%) | (12.43%) | (13.27%) |
+8 more TTM periods Free account |
|
| (8.23%) | (8.38%) | (7.65%) | (8.28%) | ||
ROIC |
(28.35%) | (27.90%) | (26.45%) | (27.77%) | |
Return on Tangible Assets |
(15.86%) | (15.28%) | (13.29%) | (14.41%) | |
Average Days of Receivables |
47.55 | 43.48 | 40.68 | 42.46 | |
Free Cash Flow per Share |
(0.29) | (0.17) | (0.55) | (0.60) | |
Free Cash Flow |
(7.86) | (4.53) | (14.71) | (16.14) | |
Capital Expenditures |
(5.34) | (3.42) | (3.50) | (2.85) | |
Piotroski F-Score |
3.00 | 4.00 | 4.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(0.89%) | (0.38%) | (3.58%) | (4.13%) | |
Accounts Receivable Turnover |
8.36 | 8.96 | 10.19 | 9.18 | |
Accounts Payable Turnover |
5.26 | 5.71 | 6.36 | 6.26 | |
Inventory Turnover |
7.43 | 7.64 | 7.66 | 7.92 | |
Average Days of Payables |
73.66 | 60.97 | 63.73 | 65.13 | |
Days of Inventory on Hand |
53.15 | 46.60 | 48.76 | 47.74 | |
Tax Rate |
(0.03) | (0.03) | (0.03) | (0.03) | |
Research and Development Expense of Revenue |
5.96% | 5.82% | 5.56% | 5.76% | |
Selling, General and Administrative Expense of Revenue |
47.25% | 47.56% | 47.34% | 48.30% | |
Share Based Compensation of Revenue |
2.06% | 2.22% | 2.30% | 2.28% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.10 | 0.04 | 0.49 | 0.52 | |
Depreciation/Fixed assets |
0.62 | 0.60 | 0.57 | 0.55 | |
Capex/Depreciation |
(0.27) | (0.17) | (0.17) | (0.14) | |
Revenue per Share |
13.10 | 12.86 | 13.11 | 12.82 | |
Operating CF per Share |
(0.09) | (0.04) | (0.42) | (0.49) | |
Capex per Share |
(0.20) | (0.13) | (0.13) | (0.11) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(6.94%) | (7.08%) | (6.52%) | (7.31%) |
Columns are period end dates